Introduction: thromboxane in biological systems and the possible impact of its inhibition.
Open Access
- 1 February 1983
- journal article
- review article
- Published by Wiley
- Vol. 15 (S1) , 7S-11S
- https://doi.org/10.1111/j.1365-2125.1983.tb02100.x
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Thromboxanes and prostacyclin: Positive and negative modulators of tumor growthBiochemical and Biophysical Research Communications, 1981
- Familial Bleeding Tendency with Partial Platelet Thromboxane Synthetase Deficiency: Reorientation of Cyclic Endoperoxide MetabolismBritish Journal of Haematology, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.Circulation, 1980
- The synthesis of prostaglandins by bovine cerebral microvesselsProstaglandins and Medicine, 1980
- Increased levels of thromboxane A2 in peripheral and coronary circulation in patients with angina pectorisThe American Journal of Cardiology, 1980
- Regional differences in prostacyclin formation by the kidneyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Endogenous formation of the prostaglandin endoperoxine metabolite, thromboxane B2, by brain tissueBiochemical and Biophysical Research Communications, 1976
- Platelets, Thrombosis and DrugsDrugs, 1975